Charles Schwab Investment Management Inc Exact Sciences Corp Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,434,855 shares of EXAS stock, worth $91 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,434,855
Previous 1,391,599
3.11%
Holding current value
$91 Million
Previous $60.2 Million
26.57%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding EXAS
# of Institutions
651Shares Held
156MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$1.15 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$765 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$761 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$341 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.2B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...